Pain Medicine, Interventional Pain Medicine · Lubbock, TX
NPI
1659368793
Since 2005
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3419 22nd St
Lubbock, TX, 79410
Phone (806) 796-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$392K
4,329 services
Medicare patients, 2024
924
Average age 75
Drug cost, 2024
$441K
10,477 prescriptions
Company payments, 2025
$32K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bolkar E Sahinler was code 64483 (nerve block injection - back), 724 times for 479 patients. In total Bolkar E Sahinler billed 4,329 services in 76 codes, and Medicare paid $392K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 64483 Nerve Block Injection - Back | Facility | 724 | 479 | $106.18 | $77K |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 320 | 28 | $0.29 | $91.36 |
| 64484 Nerve Block Injection - Back | Facility | 294 | 207 | $38.90 | $11K |
| 99204 Office E&M - New | Office | 289 | 289 | $116.92 | $34K |
| 64493 Nerve Block Injection - Back | Facility | 153 | 86 | $96.86 | $15K |
| 64494 Nerve Block Injection - Back | Facility | 151 | 86 | $54.45 | $8,222 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 149 | 80 | $0.10 | $14.41 |
| 99214 Office E&M - Established | Office | 148 | 123 | $88.69 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 142 | 129 | $12.22 | $1,735 |
| 99213 Office E&M - Established | Office | 137 | 97 | $60.23 | $8,251 |
| 20610 Joint Injection | Office | 125 | 63 | $54.60 | $6,825 |
| 62321 Nerve Block Injection - Back | Facility | 103 | 84 | $78.40 | $8,075 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 97 | 88 | $212.08 | $21K |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 96 | 87 | $63.65 | $6,111 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 83 | 36 | $6.16 | $511 |
By year: 2022 $627K for 20,838 services; 2023 $419K for 8,207 services; 2024 $392K for 4,329 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 46 | 37 | $60.90 | $2,801 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 44 | 36 | $194.77 | $8,570 |
Medicare prescription drug claims, 2024
In 2024, the drug Bolkar E Sahinler prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 4,235 prescriptions and refills. In total Bolkar E Sahinler wrote 10,477 Medicare prescriptions that cost $441K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 4,235 | 4,236 | 699 | $121K |
| Gabapentin Generic | 879 | 1,204 | 243 | $13K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 760 | 760 | 128 | $24K |
| Hydromorphone Hcl Generic | 644 | 644 | 99 | $12K |
| Pregabalin Generic | 573 | 642 | 105 | $12K |
| Morphine Sulfate Er Morphine Sulfate | 517 | 517 | 72 | $15K |
| Tramadol Hcl Generic | 475 | 475 | 143 | $3,494 |
| Fentanyl Generic | 272 | 272 | 31 | $25K |
| Tizanidine Hcl Generic | 271 | 370 | 90 | $3,963 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 222 | 222 | 84 | $4,565 |
| Oxycodone Hcl Generic | 168 | 168 | 29 | $3,856 |
| Cyclobenzaprine Hcl Generic | 157 | 197 | 54 | $1,462 |
| Meloxicam Generic | 146 | 231 | 48 | $599 |
| Methocarbamol Generic | 132 | 158 | 45 | $1,128 |
| Celecoxib Generic | 104 | 162 | 27 | $1,964 |
Brand drugs: 381 claims; generic drugs: 10,096 claims; opioid claims: 7,772.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bolkar E Sahinler $32K ($32K in general payments such as food, travel and fees) from 11 companies. The largest payer was Medtronic, Inc. with $26K.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 45 | $26K |
| Roche Diagnostics Corporation ROG.SW | 2 | $4,700 |
| Abbott Laboratories ABT | 9 | $676 |
| Abbvie Inc. ABBV | 11 | $207 |
| Globus Medical, Inc. GMED | 1 | $172 |
| MML US, Inc. | 3 | $75.43 |
| Stryker Corporation SYK | 2 | $73.09 |
| Saluda Medical Americas, Inc. | 1 | $40.28 |
| Boston Scientific Corporation BSX | 2 | $38.97 |
| Si-Bone, Inc. SIBN | 1 | $21.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.